RTLGenomics is a full service Next Generation Provider. Offering extraction, sequencing bioinformatics, and biostatistics services at a competitive price.
Initially founded in 2007 to develop diagnostic techniques for chronic wound care using molecular approaches (qPCR) rather than cloning, the company quickly expanded to molecular genomics. With the installation in 2009 of a Roche 454-FLX (and a second one in early 2010), RTL was one of the first commercial providers of 16S amplicon sequencing.
As the application of amplicon pyrosequencing expanded beyond bacterial amplicon metagenomics, RTL increased capability by adding additional assays (functional genes, fungal 18S and ITS, and multi-locus approaches), and then in 2011 purchasing two Ion Torrent PGM instruments. Also in 2011, RTL temporarily relocated to begin a remodel of its lab and office space, and hired a new CEO. In 2012, RTL added an Ion Torrent Proton instrument and doubled its laboratory staff. The company moved back to its current space in March of 2013, at which point it also began offering Illumina MiSeq sequencing as 454 began to be phased out of use. Furthering the use of Illumina platforms, RTL entered into a partnership with Texas Tech University to buy a HiSeq 2500, to be housed and operated by Texas Tech.
Between 2012 and 2015, RTL worked with Life Technologies to beta test their 16S Microbiome kit, IsoThermal kit, as well as other kits, and to become a Human Exome Certified Service Provider. In addition, the company became an early access partner in Oxford Nanopore's MINion Access Program (MAP). Also in 2015, RTL began investing in long read technologies by purchasing a PacBio RSII, and then a BioNano Irys and a PacBio Sequel in 2016.
In 2016, RTLGenomics was created to better focus on the genomic and metagenomics. RTLGenomics also became a PacBio Certified Service Provider and an Illumina Certified Service Provider.
After several successful years at the previous lab, RTL Genomics has relocated once again. Beginning in March of 2019, all lab work will be done out of our new location. We are excited to see where the future leads and hope to continue at the forefront of scientific discovery.
For more information on the people behind the company, please visit our Bio page here.